Ensign Research And Ddevelopement To Revenue from 2010 to 2025

ENSG Stock  USD 132.50  0.37  0.28%   
Ensign's Research And Ddevelopement To Revenue is steady over the last several years with stable swings. Research And Ddevelopement To Revenue is predicted to flatten to 0.00. Research And Ddevelopement To Revenue is the ratio of a company's research and development expenses to its total revenue, indicating how much of the revenue is invested back into developing new products or services. View All Fundamentals
 
Research And Ddevelopement To Revenue  
First Reported
2010-12-31
Previous Quarter
0.0
Current Value
0.0
Quarterly Volatility
0.0
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Ensign financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ensign's main balance sheet or income statement drivers, such as Depreciation And Amortization of 87.4 M, Interest Expense of 8.2 M or Total Revenue of 4.5 B, as well as many indicators such as Price To Sales Ratio of 1.58, Dividend Yield of 0.0023 or PTB Ratio of 7.38. Ensign financial statements analysis is a perfect complement when working with Ensign Valuation or Volatility modules.
  
Check out the analysis of Ensign Correlation against competitors.

Currently Active Assets on Macroaxis

When determining whether Ensign Group is a strong investment it is important to analyze Ensign's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ensign's future performance. For an informed investment choice regarding Ensign Stock, refer to the following important reports:
Check out the analysis of Ensign Correlation against competitors.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ensign. If investors know Ensign will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ensign listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.207
Dividend Share
0.24
Earnings Share
4.13
Revenue Per Share
72.801
Quarterly Revenue Growth
0.15
The market value of Ensign Group is measured differently than its book value, which is the value of Ensign that is recorded on the company's balance sheet. Investors also form their own opinion of Ensign's value that differs from its market value or its book value, called intrinsic value, which is Ensign's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ensign's market value can be influenced by many factors that don't directly affect Ensign's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ensign's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ensign is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ensign's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.